A. L. Tárnoky

595 total citations
41 papers, 460 citations indexed

About

A. L. Tárnoky is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Spectroscopy. According to data from OpenAlex, A. L. Tárnoky has authored 41 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Spectroscopy. Recurrent topics in A. L. Tárnoky's work include Protein Interaction Studies and Fluorescence Analysis (15 papers), Mass Spectrometry Techniques and Applications (6 papers) and Cystic Fibrosis Research Advances (6 papers). A. L. Tárnoky is often cited by papers focused on Protein Interaction Studies and Fluorescence Analysis (15 papers), Mass Spectrometry Techniques and Applications (6 papers) and Cystic Fibrosis Research Advances (6 papers). A. L. Tárnoky collaborates with scholars based in United Kingdom, Italy and Denmark. A. L. Tárnoky's co-authors include Robert Finney, A. N. Lestas, A.J. Karlish, Francisco M. Salzano, Lorenzo Minchiotti, Monica Galliano, L.R. Weitkamp, J.V. Neel, Francesco Porta and R. A. Geerdink and has published in prestigious journals such as Nature, The Lancet and Biochemical Journal.

In The Last Decade

A. L. Tárnoky

37 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. L. Tárnoky United Kingdom	13	233	76	65	59	56	41	460
B. A. Skålhegg Norway	12	85 0.4×	54 0.7×	33 0.5×	24 0.4×	133 2.4×	18	484
Kathryn N. Ham Australia	12	119 0.5×	24 0.3×	45 0.7×	11 0.2×	50 0.9×	23	460
Dietmar Nagel Germany	12	81 0.3×	72 0.9×	45 0.7×	20 0.3×	36 0.6×	30	422
K. Weigand Germany	13	194 0.8×	96 1.3×	47 0.7×	23 0.4×	92 1.6×	36	476
Christopher Vickers Australia	10	107 0.5×	14 0.2×	41 0.6×	21 0.4×	42 0.8×	13	513
Volker E. Dube United States	12	186 0.8×	21 0.3×	39 0.6×	19 0.3×	28 0.5×	27	430
Robin S. Jones United Kingdom	11	157 0.7×	81 1.1×	40 0.6×	9 0.2×	85 1.5×	20	381
D. Bucher Denmark	10	123 0.5×	25 0.3×	19 0.3×	18 0.3×	30 0.5×	18	376
Valerie Bush United States	11	122 0.5×	36 0.5×	113 1.7×	34 0.6×	7 0.1×	22	404
I Kupke Germany	9	96 0.4×	13 0.2×	47 0.7×	50 0.8×	73 1.3×	25	399

Countries citing papers authored by A. L. Tárnoky

Since Specialization

Citations

This map shows the geographic impact of A. L. Tárnoky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. L. Tárnoky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. L. Tárnoky more than expected).

Fields of papers citing papers by A. L. Tárnoky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. L. Tárnoky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. L. Tárnoky. The network helps show where A. L. Tárnoky may publish in the future.

Co-authorship network of co-authors of A. L. Tárnoky

This figure shows the co-authorship network connecting the top 25 collaborators of A. L. Tárnoky. A scholar is included among the top collaborators of A. L. Tárnoky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. L. Tárnoky. A. L. Tárnoky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galliano, Monica, Ulrich Kragh‐Hansen, A. L. Tárnoky, et al.. (1999). Genetic variants showing apparent hot-spots in the human serum albumin gene. Clinica Chimica Acta. 289(1-2). 45–55. 13 indexed citations

Savva, D., Bing Li, Ulrich Kragh‐Hansen, et al.. (1998). Genetic variation in human serum albumin: a 313 Lys→Asn mutation in Albumin Reading identified by PCR analysis. Clinica Chimica Acta. 270(2). 195–201. 3 indexed citations

Nielsen, H.L., Ulrich Kragh‐Hansen, Lorenzo Minchiotti, et al.. (1997). Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1342(2). 191–204. 20 indexed citations

Tárnoky, A. L., D. Savva, & J. Frohlich. (1995). Classification of an Alloalbumin. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 32(4). 434–434. 2 indexed citations

Tárnoky, A. L., et al.. (1992). Genetic variants of serum albumin: a study of albumin Kashmir.. PubMed. 29(5). 383–7. 2 indexed citations

Tárnoky, A. L., et al.. (1991). Nature of the HABA binding to human serum albumin. Biochemical Society Transactions. 19(3). 333S–333S. 2 indexed citations

Savva, D., et al.. (1990). Genetic characterization of an alloalbumin, albumin Kashmir, using gene amplification and allele-specific oligonucleotides.. PubMed. 266(2). 615–7. 11 indexed citations

Galliano, Monica, Lorenzo Minchiotti, Monica Stoppini, & A. L. Tárnoky. (1989). A new proalbumin variant: Albumin Jaffna (−1 Arg→Leu). FEBS Letters. 255(2). 295–299. 13 indexed citations

Tárnoky, A. L.. (1982). Warfarin and albumin.. BMJ. 285(6344). 812.2–812. 2 indexed citations

10.

Tárnoky, A. L.. (1980). Genetic and Drug-Induced Variation in Serum Albumin. Advances in clinical chemistry. 21. 101–146. 64 indexed citations

11.

Tárnoky, A. L., et al.. (1978). The Vickers SP 120 analyser: an instrument evaluation. Journal of Analytical Methods in Chemistry. 1(1). 36–39.

12.

Izquierdo, J.M., et al.. (1971). Bisalbuminaemia in a Spanish family: characterization of the albumin variant. Journal of Clinical Pathology. 24(6). 515–517. 9 indexed citations

13.

Weitkamp, L.R., D C Shreffler, Jeff Robbins, et al.. (1967). An Electrophoretic Comparison of Serum Albumin Variants from Nineteen Unrelated Families. Human Heredity. 17(5). 399–405. 26 indexed citations

14.

Tárnoky, A. L., et al.. (1966). BIOCHEMICAL EFFECTS OF SHORT‐TERM TREATMENT WITH CARBENOXOLONE DISODIUM. British Journal of Pharmacology and Chemotherapy. 26(2). 412–420. 15 indexed citations

15.

Tárnoky, A. L.. (1964). A Screening method for blood-urea estimations. Clinica Chimica Acta. 10(3). 253–258. 5 indexed citations

16.

Tárnoky, A. L.. (1961). AUTOMATION IN CLINICAL BIOCHEMISTRY. The Lancet. 277(7182). 880–880. 1 indexed citations

17.

Karlish, A.J. & A. L. Tárnoky. (1960). MUCOVISCIDOSIS AS A FACTOR IN CHRONIC LUNG DISEASE IN ADULTS. The Lancet. 276(7149). 514–515. 33 indexed citations

18.

Finney, Robert & A. L. Tárnoky. (1960). The Pharmacological Properties of Glycyrrhetinic Acid Hydrogen Succinate (Disodium Salt). Journal of Pharmacy and Pharmacology. 12(1). 49–58. 38 indexed citations

19.

Brown, Holly, Robert Finney, William G. Smith, et al.. (1959). GLYCYRRHETINIC ACID HYDROGEN SUCCINATE (DISODIUM SALT). The Lancet. 274(7101). 492–493. 14 indexed citations

20.

Tárnoky, A. L., et al.. (1951). The Action of p -Aminosalicylic Acid on Prothrombin Time in Man. Journal of Clinical Pathology. 4(4). 478–486. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact